title: Adult treatment panel III and the management of dyslipidemia risk factors.
abstract: The new treatment guidelines issued by the Third National Cholesterol Education Program Adult Treatment Panel III depart from the recommendations of the previous edition, the ATP II, in a number of significant ways. Perhaps the most significant are the lowering of the target level of low-density lipoprotein to <100 mg/dL and the introduction of the coronary heart disease risk equivalent. As a result, many more individuals have been identified as requiring intervention, and others will require more aggressive modalities, including cholesterol lowering pharmacotherapy.
authors: University of Cincinnati, Highland Heights, KY 41076, USA. esteinmrl@aol.com
authors: Evan A
authors: EA
authors: Stein
mesh_terms: D000328:Adult; D000367:Age Factors; D008076:Cholesterol, HDL / Q000097:blood / Q000187:drug effects; D008078:Cholesterol, LDL / Q000097:blood / Q000187:drug effects*; D003324:Coronary Artery Disease / Q000188:drug therapy* / Q000453:epidemiology; D050171:Dyslipidemias / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood; D014481:United States / Q000453:epidemiology
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides